Sanovas, Inc. is focused on developing innovative medical technologies aimed at enhancing minimally invasive surgical procedures. The company is dedicated to creating a comprehensive range of diagnostic and therapeutic tools that prioritize affordability, accessibility, and safety across various medical specialties. Their approach emphasizes the importance of intervention through advanced access, imaging, and measurement technologies, which empower physicians to conduct more procedures in diverse settings. This commitment to innovation is reflected in their goal to establish ubiquitous medical technologies that can be utilized daily in healthcare environments.

The company’s portfolio includes a variety of investigational medical devices, such as Via, VasZeppelin, MicroCam, StablePath, PhysioSense, CytoVas, and NanoVas, which are designed to redefine surgical intervention. These technologies are still in the development phase and have not yet received approval for use in the United States. Sanovas aims to accelerate the advancement of these tools to ensure they meet the evolving needs of healthcare providers and patients, ultimately transforming the landscape of minimally invasive surgery.

United States

Sanovas, Inc. is a life science asset holding company that is developing and accelerating companies that create medical technologies which are advancing the next generation of minimally invasive surgical tools and technologies.

Sanovas

Company Details